CATIE: HepC Info Update

Some Highlights:

 – Discovery may aid development of hepatitis C vaccine

 – Didanosine, higher hepatitis C virus viral load predict liver fibrosis in HIV/HCV co-infected people

 – New hepatitis C drug telaprevir allows shorter hepatitis therapy for some

 – Insulin resistance quadruples liver cancer risk in people with HIV/hepatitis C co-infection

 – Coffee consumption reduces side-effects in people on hepatitis C treatment

New Journal Articles:

 – Do Crack Smoking Practices Change With the Introduction of Safer Crack Kits? – Canadian Journal of Public Health, June 2011, in English

 – Effects of a Heroin-Assisted Treatment Clinic on Community Environment – Canadian Journal of Public Health, June 2011, abstract in English

 – Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) – Canadian Journal of Gastroenterology, September 2011, in English

 – Hepatitis Issue – Current Opinion in HIV and AIDS, September 2011, in English

 – Hepatitis C Direct Acting Antivirals: The New Standard of Care – Clinics in Liver Disease, August 2011, in English

  – Limited Use of Interleukin 28B in the Setting of Response-Guided Treatment with Detailed On-Treatment Virological Monitoring – Hepatology, September 2011, in English

To view the entire update, with links to articles, click here.